Nivolumab

Biorbyt

Nivolumab [946414-94-4]

10

946414-94-4

Research Use Only

>98%

146 kDa

Nivolumab anti-PD-1) is a genetically engineered fully human immunoglobulin Ig) G4 monoclonal antibody directed against the negative immunoregulatory human cell surface receptor programmed death-1PD-1PCD-1) with immune checkpoint inhibitory and antineoplastic activities.

-20°C

12352200